Page last updated: 2024-11-05

tinidazole and Acute Myelogenous Leukemia

tinidazole has been researched along with Acute Myelogenous Leukemia in 2 studies

Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.

Research Excerpts

ExcerptRelevanceReference
"To find out if the administration of tinidazole, in patients with acute leukemia and negative coprological test, at the beginning of the CT, decreases the incidence of amoebic colitis during the induction to remission."3.91[Eficacia del tinidazol en la profilaxis terapéutica de la colitis amebiana en pacientes con leucemia aguda de novo que reciben quimioterapia intensiva]. ( Alvarado-Ibarra, M; Álvarez-Vera, JL; Arana-Luna, LL; de la Peña-Celaya, JA; Espitia-Ríos, ME; Mena-Zepeda, V; Ortiz-Zepeda, M; Zúñiga, JMP, 2019)
"Tinidazole was indicated, 2 g/day for 5 days in the first week of CT started."1.51Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy. ( Alvarado-Ibarra, M; Álvarez-Vera, JL; Arana-Luna, LL; Espitia-Ríos, ME; Mena-Zepeda, V; Ortiz-Zepeda, M; Peña-Celaya, JA; Zúñiga, JMP, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arana-Luna, LL2
Álvarez-Vera, JL2
Peña-Celaya, JA1
Mena-Zepeda, V2
Ortiz-Zepeda, M2
Espitia-Ríos, ME2
Zúñiga, JMP2
Alvarado-Ibarra, M2
de la Peña-Celaya, JA1

Other Studies

2 other studies available for tinidazole and Acute Myelogenous Leukemia

ArticleYear
Tinidazole efficacy for amebic colitis therapeutic prophylaxis in patients with de novo acute leukemia receiving intensive chemotherapy.
    Gaceta medica de Mexico, 2019, Volume: 155, Issue:Suppl 1

    Topics: Adolescent; Adult; Aged; Amebicides; Antineoplastic Combined Chemotherapy Protocols; Dysentery, Ameb

2019
[Eficacia del tinidazol en la profilaxis terapéutica de la colitis amebiana en pacientes con leucemia aguda de novo que reciben quimioterapia intensiva].
    Gaceta medica de Mexico, 2019, Volume: 155, Issue:Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Colitis; Dysentery, Amebic; Female; Humans; Leukemia

2019